Skip to main content

Senior Healthcare Leaders


Right Expertise At The Right Time


Flexible Strategic And Operational Support


Tailored Team To The Evolving Project Needs


Cross-functional And Functional Leadership

2 Bridge Tiger Teams

We take care of our clients’ projects as if they are our own by carefully assembling the 2 Bridge Tiger Team, a team of R&D experts and healthcare executives from various domains that provides knowledge, experience, and hands-on support.

Our Tiger Teams are agile and highly adaptable throughout the collaboration; ensuring you have flexible access to the right expertise at the right time; avoiding a cost-intensive trial-and-error process.

Why Choose Us

Speed & Efficiency

Transparency & Oversight

End-to-end Expertise

Focus on Company Goals

Project Portfolio

Therapeutic Area

  • Oncology
  • Immunology-Rheumatology-Transplantation
  • Neurology
  • Infectious diseases
  • Metabolic disorders
  • Respiratory Tract diseases
  • Gastrointestinal disorders
  • Ophthalmology
  • Dermatology
  • Geroscience
  • Endocrinology
  • Cardiovascular diseases
  • Others


  • small molecule
  • biological
  • RNA-based
  • ATMP
  • platform
  • Meddev
  • herbal
  • microbiome
  • Meddev/combination

Ronald Van Brempt

Senior Medical Expert

MD, Board certified Anesthesiologist, MSc in Structural Molecular Biology

Belgium has a long, historical tradition of medical breakthroughs. A world-class medical system has grown on Belgian soil from these historical roots. In the late 20th century, Belgium became the birthplace of a thriving pharmaceutical and biotech environment. Working alongside the 2 Bridge experts for the people and companies making this wonder happen is a privilege. Translating science into therapies for patients in Belgium, Europe, and the world is what 2 Bridge stands for!

Listen to patients, nurses, and physicians. They will tell you all you need to know about the why, what and when of novel therapies for unmet medical needs.

Case Study


The client is a therapeutic biotech, focusing on the discovery and development of innovative medicines for patients suffering from central and peripheral neuropathies. 2 Bridge was brought on board to help the company to conduct an in-depth selection of the 4 preselected indication(s) and identify an appropriate clinical path to value generation for their candidate compounds.

Our Approach

2 Bridge Tiger Team consisting of different disciplines acted as a one-stop provider that offers a complete service package from market research, KOL interaction, literature research, and scientific report to early clinical development plan.


Together we developed a clear clinical positioning of assets and created a Clinical Development Plan from FIH up to Ph2a proof-of-concept studies in 2 preferred indications.

With a global view on development, she combines the biological and medical sides of a project, as well as its technical CMC dimension.
A senior scientist with 10 years of experience in oncology research, at academia and industry at the interface between clinical and preclinical research
An enthusiastic clinical expert with more than 20 years of experience in setting up and leading clinical studies and teams
A senior medical expert with extensive experience in clinical care and involvement in the development of novel drugs in many indications

A Selection of our Clients


There is not enough room in this survey to describe the expertise, experience, professionalism, organization, collegiality, and the highest quality of work output. Our work with 2 Bridge was extraordinary. Each program had a very experienced program leader for whom milestone achievement within agreed timelines was a recurrent and purposeful agenda item. Each team member we worked with had many years of experience and was able to apply that experience to the programs. Our collaboration with 2 Bridge was a true partnership that helped us (a small US-based company) establish a real presence in Europe – with enhanced access to EU KOLs, EU regulatory expertise, and an understanding of the nuances of clinical development in Europe and Eastern Europe.

Chief Medical Officer from a Biotech

Our solutions

Translational Development

Read more ...

CMC Solutions

Read more ...

Quality As A Service

Read more ...

Clinical Development

Read more ...

Company Building

Read more ...